Two Sigma Investments LP Sells 8,883 Shares of Transcat, Inc. (NASDAQ:TRNS)

Two Sigma Investments LP cut its holdings in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 62.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,273 shares of the scientific and technical instruments company's stock after selling 8,883 shares during the quarter. Two Sigma Investments LP owned approximately 0.06% of Transcat worth $558,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Jones Financial Companies Lllp raised its position in shares of Transcat by 686.7% during the 4th quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company's stock valued at $37,000 after buying an additional 309 shares in the last quarter. Aquatic Capital Management LLC increased its holdings in Transcat by 1,052.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company's stock worth $122,000 after acquiring an additional 1,052 shares in the last quarter. Morgan Dempsey Capital Management LLC purchased a new position in shares of Transcat in the fourth quarter worth about $143,000. SG Americas Securities LLC purchased a new position in Transcat during the fourth quarter worth about $182,000. Finally, KLP Kapitalforvaltning AS acquired a new stake in shares of Transcat during the fourth quarter valued at about $190,000. Institutional investors own 98.34% of the company's stock.

Analyst Ratings Changes

TRNS has been the subject of a number of recent analyst reports. HC Wainwright reaffirmed a "buy" rating and set a $116.00 price target (up from $106.00) on shares of Transcat in a report on Wednesday, May 21st. Wall Street Zen upgraded shares of Transcat from a "sell" rating to a "hold" rating in a research report on Wednesday, May 28th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $114.00.

Transcat Stock Performance

NASDAQ:TRNS traded up $1.83 during midday trading on Thursday, reaching $77.39. 158,186 shares of the company traded hands, compared to its average volume of 85,998. The firm has a market capitalization of $721.12 million, a price-to-earnings ratio of 41.83 and a beta of 0.75. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.42 and a quick ratio of 1.98. The company has a fifty day moving average price of $82.28 and a 200 day moving average price of $87.67. Transcat, Inc. has a twelve month low of $67.56 and a twelve month high of $147.12.

Transcat (NASDAQ:TRNS - Get Free Report) last issued its quarterly earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share for the quarter, missing analysts' consensus estimates of $0.66 by ($0.02). Transcat had a net margin of 6.22% and a return on equity of 7.23%. The business had revenue of $77.13 million for the quarter, compared to analysts' expectations of $76.40 million. The company's revenue for the quarter was up 8.8% compared to the same quarter last year. On average, analysts expect that Transcat, Inc. will post 2.3 EPS for the current fiscal year.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.